|
Index of reports
> Death (193)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 193 Next >>
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a individual with unspecified qualification from United States on 2012-08-22
Patient: female
Reactions: Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Dosage: 375/m2, unk
Indication: Idiopathic Thrombocytopenic Purpura
Rituxan
Indication: Lupus-Like Syndrome
Rituxan
Other drugs received by patient: Prednisone TAB; Prednisone TAB; Panglobulin; Calcium Carbonate; Ergocalciferol; Zoledronic Acid; Iron Polysaccharide; Conjugated Estrogens; Imuran; Omeprazole; Sumatriptan; Mirtazapine; Ascorbic Acid; Sulfamethoxazole; Prednisone TAB; Romiplostim; Atenolol; Prednisone TAB; Danazol; Acetaminophen; Alprazolam
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient: male
Reactions: Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 68 year old male
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-17
Patient: 68 year old male
Reactions: Hepatitis B
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Splenic Marginal Zone Lymphoma
Doxorubicin Hydrochloride
Indication: Splenic Marginal Zone Lymphoma
Prednisone TAB
Indication: Immunosuppression
Rituxan
Indication: Splenic Marginal Zone Lymphoma
Vincristine
Indication: Splenic Marginal Zone Lymphoma
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient: male, weighing 91.7 kg (201.7 pounds)
Reactions: Pneumonia, Anaemia, Pancytopenia, Febrile Neutropenia, Respiratory Failure, Muscle Abscess, Thrombocytopenia, Cardiac Arrest
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 150 milligram
Start date: 2012-05-14
Rituxan
Start date: 2012-06-22
Rituxan
Start date: 2012-07-19
End date: 2012-07-20
Rituxan
Dosage: 17.8571 milligram
Start date: 2012-08-04
Vidaza
Dosage: 150 milligram
Start date: 2012-05-14
Vidaza
Dosage: 150 milligram
Start date: 2012-07-19
End date: 2012-07-20
Other drugs received by patient: Procrit; Fluticasone Propionate; Folic Acid; Hydrocortisone-Pramoxine; Metoprolol Tartrate; Rosuvastatin; Meropenem; Vancomycin; Dextrose; Acetaminophen; Calcium + Vitamin D; Ciprofloxacin-Dexamethasone Otic; Diphenhydramine Hydrochloride; Filgrastim; Multi-Vitamins; Phenylephrine Hydrochloride; Acetaminophen; Naproxen; Whole Blood; Prednisone TAB; Vitamin B-12; Acetaminophen; Benazepril Hydrochloride; Augmentin '500'; Amlodipine; Omeprazole; Sodium Chloride
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-15
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Activase
Indication: Cerebral Artery Occlusion
Rituxan
Indication: Anaemia Haemolytic Autoimmune
Possible Rituxan side effects in 70 year old
Reported by a pharmacist from United States on 2012-08-09
Patient: 70 year old
Reactions: Death, Histiocytosis Haematophagic, Chills
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Indication: Lymphoma
Start date: 2012-05-14
Bendamustine Hydrochloride
Start date: 2012-05-15
Rituxan
Dosage: splitted dose.
Start date: 2012-05-15
Rituxan
Indication: Lymphoma
Start date: 2012-05-14
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-08-08
Patient: female
Reactions: Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Actemra
Indication: Rheumatoid Arthritis
Rituxan
Indication: Rheumatoid Arthritis
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-08-03
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Coumadin
Possible Rituxan side effects in 85 year old
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: 85 year old
Reactions: Cardiomyopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Cyclophosphamide
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Prednisone
Dosage: reduced dose
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: daily for 5 days
Radiotherapy
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Dosage: reduced dose
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: reduced dose
Other drugs received by patient: Neupogen
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-08-02
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-07-31
Patient: female
Reactions: B-Cell Lymphoma Refractory
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in 56 year old female
Reported by a consumer/non-health professional from China on 2012-07-31
Patient: 56 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-26
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a physician from United States on 2012-07-26
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-23
Patient: female
Reactions: Pulmonary Hypertension, Lung Consolidation, Regurgitation, Pneumonia, Dyspnoea Exertional, Oxygen Consumption Increased, Cough
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Digoxin; Lasix; Methotrexate; Prednisone; Telmisartan
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: male, weighing 86.2 kg (189.6 pounds)
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in
Reported by a physician from United States on 2012-07-17
Patient:
Reactions: Thrombosis, Gastrointestinal Perforation, Left Ventricular Dysfunction, Sudden Death, Blood Disorder, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Bevacizumab
Dosage: on day 1, every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Rituxan
Dosage: every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: every 21 days for a maximum of 8 cycles
Indication: Diffuse Large B-Cell Lymphoma
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: male
Reactions: Fungal Infection, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 2
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 3
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 4
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 3
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 2
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 4
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1
Possible Rituxan side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17
Patient:
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Rituxan
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Rituxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient: male
Reactions: Pneumonia, Lung Infiltration, Respiratory Distress, Cough
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-12
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Possible Rituxan side effects in female
Reported by a physician from United States on 2012-07-12
Patient: female
Reactions: Death, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Actemra
Indication: Rheumatoid Arthritis
Rituxan
Indication: Rheumatoid Arthritis
Possible Rituxan side effects in 69 year old female
Reported by a individual with unspecified qualification from Japan on 2012-07-12
Patient: 69 year old female
Reactions: Hepatic Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Rituxan
Other drugs received by patient: Prednisolone; Doxorubicin Hydrochloride; Cyclophosphamide; Vincristine Sulfate
Possible Rituxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-12
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Actemra
Indication: Product Used FOR Unknown Indication
Rituxan
Indication: Rheumatoid Arthritis
Page 1 Next >>
|
